StockNews.com downgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a report issued on Thursday morning. A number of other analysts have also commented on DXCM. Barclays lifted their target price on shares of DexCom from $110.00 to $115.00 in a report on Monday, May 1st. Citigroup […]
DexCom (NASDAQ:DXCM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday. Several other research analysts have also weighed in on DXCM. Morgan Stanley assumed coverage on shares of DexCom in a research note on Tuesday, May 30th. They set […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen brokerages that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and one has assigned a strong buy recommendation to […]
Silvant Capital Management LLC decreased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 253,000 shares of the medical device company’s stock after selling 3,082 shares during the quarter. DexCom accounts for […]
Lynch Asset Management Inc. lowered its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 31.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,000 shares of the medical device company’s stock after selling 3,700 shares during the quarter. Lynch Asset Management Inc.’s […]